OOIR: Observatory of International Research

Papers

(The H4-Index of Current Oncology Reports is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	164
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	162
New Developments in VHL-Associated Neuroendocrine Neoplasms	128
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	114
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	86
Immunotherapy in Biliary Tract Cancers: Where Are We?	78
Brain Prehabilitation for Oncologic Surgery	64
Surgical Management of Melanoma: Advances and Updates	59
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	51
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	51
NRG1 Fusions: The New Kid on the Block	47
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	45
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	44
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	41
Treatment of Metastatic Melanoma in the Elderly	41
Fatty Acid Metabolism and Cancer Immunotherapy	40
Management of Upper Tract Urothelial Carcinoma	40
Management of In-Transit Metastases	40
Head and Neck Mucosal Melanoma: Where Are We Now?	39
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	38
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	36
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	35
Anti-PD-1: When to Stop Treatment	33
The Microbiome in Advanced Melanoma: Where Are We Now?	33
Engineered T Cells: CAR T Cell Therapy and Beyond	33

The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	33
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	32
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	32
An Overview of Angiogenesis in Bladder Cancer	32
Cellular Therapy in NSCLC: Between Myth and Reality	31
Current Trends and Challenges of Microbiome Research in Prostate Cancer	30
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	30
The Difficult Airway in Patients with Cancer	30